The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients
- 1 December 1997
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 27 (6) , 1015-1021
- https://doi.org/10.1016/s0168-8278(97)80145-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based LymphomasNew England Journal of Medicine, 1995
- Measurement by the polymerase chain reaction of the Epstein‐Barr virus load in infectious mononucleosis and AIDS‐related non‐Hodgkin's lymphomasJournal of Medical Virology, 1995
- Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferationThe Lancet, 1995
- Epstein-Barr virus persistence and virus-associated tumoursThe Lancet, 1994
- Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapyCancer, 1993
- Influence of human leukocyte antigen matching on liver allograft survival and rejection: “The dualistic effect”Hepatology, 1993
- K-tuple frequency in the human genome and polymerase chain reactionNucleic Acids Research, 1991
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma GlobulinNew England Journal of Medicine, 1988
- Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1984